Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05333016
Other study ID # NSH Caring 4 Cancer Caregivers
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 15, 2023
Est. completion date December 31, 2024

Study information

Verified date March 2024
Source Nova Scotia Health Authority
Contact Melanie Keats, PhD
Phone 902-494-7173
Email melanie.keats@dal.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary goal of this study will be to assess the feasibility and acceptability of a partner-based 12-week exercise intervention for cancer caregivers and their care recipient. The researchers will also explore the preliminary effectiveness of the exercise program on caregiver burden and physical and psychological health of both the family caregiver and the care recipient.


Description:

NEED: Cancer has been characterized as a family affair, as it is a disease in which both the patient and their family members are confronted by considerable physical and psychological stressors. With an anticipated 80% increase in the average number of new cancer diagnoses by 2030 and rapidly escalating health care costs, there has been a shift to outpatient and home-based care. In doing so, family members are increasingly being called upon to participate as informal caregivers (i.e., an individual who provided uncompensated care). Despite being a key partner in the supportive care of the cancer patient, family caregivers are often inadequately prepared or supported to take on this critical role, subsequently putting their own health and well-being at risk and by extension, that of the cancer patient/survivor. Preliminary data suggests that exercise interventions show promise in mitigating caregiver burden and improving health outcomes for both the caregiver and the patient/survivor. To date, however only two studies have examined the benefit of exercise interventions on family caregiver and patient outcomes within the cancer care context. GOAL: The primary goal of this study will be to assess the feasibility and acceptability of a partner-based 12-week exercise intervention. The investigators will also explore the preliminary effectiveness of the exercise program on caregiver burden and physical and psychological health of both the family caregiver and the care recipient. WHO: Participants will include adult primary caregivers and cancer patients/survivors of all cancers and stages at any point along the cancer care trajectory. HOW: Using both surveys and participant interviews, the participant experience and impact (e.g., physical and psychological health benefits) of a 12-week, partner-based exercise intervention will be evaluated. The 12-week exercise program will include a combination of aerobic, resistance, balance, and flexibility exercises delivered in a partner-based setting twice weekly at a dedicated cancer and exercise lab.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria (all): - 18+ years - able to perform discontinuous low intensity physical activity at a minimum - able to provide informed written consent in English. Inclusion Criteria (cancer patients/survivors) - are along any stage of the cancer continuum (i.e., pre-treatment, receiving active treatment, and up to 5 years post-treatment) Inclusion Criteria (informal caregivers) - must be currently providing physical and/or psychological support to an adult (+18 years) cancer patient/survivor - not be exceeding current Canadian physical activity guidelines (i.e., 150 minutes of moderate-to-vigorous physical activity per week) Exclusion Criteria (all): - Patients/survivors and caregivers will be excluded from the study if they have any medical conditions that would contraindicate exercise Exclusion Criteria (informal caregivers) - Bereaved caregivers

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Multimodal exercise
Multimodal exercise programming including aerobic, resistance, balance, and flexibility exercises

Locations

Country Name City State
Canada Physical Activity and Cancer (PAC) Lab Halifax Nova Scotia

Sponsors (1)

Lead Sponsor Collaborator
Nova Scotia Health Authority

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment Participant accrual as defined as the number of eligible participant dyads who consents to participate Through study completion, about 2 years
Primary Intervention Adherence Participant program adherence calculated as percentage of exercise sessions completed divided by total number of available exercise sessions over 12-week intervention Through study completion, about 2 years
Primary Adverse Events Adverse and serious adverse events will be recorded Through study completion, about 2 years
Primary Attrition Participant attrition calculated as percentage of patients who complete 12-week study divided by number who withdraw from study Through study completion, about 2 years
Primary Participant Satisfaction Participant satisfaction will be assessed by semi-structured interviews (no min/max) Post intervention, about 12-weeks after baseline
Secondary Caregiver Burden Assessed by the 22-item Zarit Burden Interview (ZBI). Responses are scored on a 5-point Likert scale ranging from 0 (never) to 4 (nearly always) with the sum of scores ranging from 0 to 88 (higher scores indicate higher burden) Pre to post intervention (12-week change)
Secondary Body Mass Index (BMI) Weight (kg) and height (m) will be used to calculate BMI Pre to post intervention (12-week change)
Secondary Body Composition Waist and hip circumference Pre to post intervention (12-week change)
Secondary Resting heart rate Resting heart rate Pre to post intervention (12-week change)
Secondary Resting Blood Pressure Resting systolic and diastolic blood pressure Pre to post intervention (12-week change)
Secondary Aerobic Fitness The 6-minute walk test will be used to assess aerobic capacity Pre to post intervention (12-week change)
Secondary Upper Body Strength Grip strength will be measured using a hand-held dynamometer Pre to post intervention (12-week change)
Secondary Muscular Endurance Lower body muscular endurance will be assessed using the 30-second sit-to-stand Pre to post intervention (12-week change)
Secondary Balance Balance will be assessed using the one-legged stance Pre to post intervention (12-week change)
Secondary Flexibility Flexibility will be assessed using the sit-and-reach and shoulder flexibility Pre to post intervention (12-week change)
Secondary Caregiver Quality of Life Quality of life will be assessed using the Short-Form Health Survey- SF-36. The SF-36 consists of 36 questions that cover 8 health domains/subscales (physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health). The total scale score ranges from 0 to 100 with higher values representing higher quality of life. Pre to post intervention (12-week change)
Secondary Cancer Patient Quality of Life Quality of life for cancer patients will be assessed using the Functional Assessment of Cancer Therapy - General survey. The combined 27-item scale provides subscale scores physical (7-items), functional (7-items), emotional (6-items), and social/family (7-items) well-being. The sum of scores on the five domains evaluates a participants' quality of life with higher scores (ranging from 0-108) denoting higher quality of life. Pre to post intervention (12-week change)
Secondary Cancer Patient Fatigue Fatigue will be assessed using the 13-item Functional Assessment of Chronic Illness Therapy - Fatigue survey. Scores range from 0-52 with higher scores indicating better functioning/less fatigue Pre to post intervention (12-week change)
Secondary Self-Reported Physical Activity Physical activity will be assessed using the Godin Leisure Time Exercise Questionnaire. Total score ranges from 0 to no maximum. Pre to post intervention (12-week change)
Secondary General Health (EuroQol) 5 Dimension - 5 Level Mobility, self-care, usual activities, pain/discomfort, anxiety/depression (EuroQol-5Dimension-5Level; EQ-5D-5L); higher scores indicate higher problems (range 0-1) Pre to post intervention (12-week change)
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients